[HTML] from eje.orgJG Verbalis, S Adler, RW Schrier, T Berl… - European Journal of …, 2011 - eje.org Results In patients with SIADH, improvement in serum [Na + ] was significantly greater (P<0.0001) with tolvaptan than placebo over the first 4 days of therapy as well as the entire 30-day study, with minimal side effects of increased thirst, dry mouth, and urination. Only ... Cited by 3 - Related articles - All 5 versions
MR Green, JE Woolery… - American Journal of …, 2011 - journals.lww.com Melanoma is a relatively common cancer and is often associated with a dire prognosis once diagnosed as metastatic. Immunomodulatory therapy with high-dose bolus interleukin-2 may provide durable responses, albeit in a small subset of those afflicted with metastatic ... All 3 versions
[HTML] from oxfordjournals.orgK Yamaguchi, N Shijubo, T Kodama, K Mori… - Japanese Journal of …, 2011 - FPCR Ectopic antidiuretic hormone syndrome is a medical emergency characterized by dilutional hyponatremia. Clinical effectiveness of the vasopressin V2 receptor antagonist mozavaptan was evaluated in 16 patients. In short-term (7-day) treatment with the drug, serum sodium ... Related articles - All 4 versions
MB Potts, AF DeGiacomo, L Deragopian… - …, 2011 - journals.lww.com BACKGROUND: Syndrome of inappropriate antidiuretic hormone secretion (SIADH) is the most common cause of hyponatremia in hospitalized patients and is frequently associated with neurologic disorders and neurosurgical procedures. Traditional therapies such as fluid restriction, ... Related articles - All 3 versions
沪公网安备号：31010402006960 （网站）31010405000484 （蝌蝌APP）
安全保密
